ICM
RMD icon

Infini Capital Management’s ResMed RMD Stock Holding History

Infini Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+4,000
New +$723K ﹤0.01% 5

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Infini Capital Management's RMD Position: Q3 2023 in Review

Infini Capital Management opened a new position in ResMed (RMD) in Q3 2023: 4,000 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #5 among its holdings.

657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Infini Capital Management held 4,000 shares of ResMed worth $0 as of Q3 2023.
  • ResMed was a new Infini Capital Management position in Q3 2023.
  • ResMed made up ﹤0.01% of Infini Capital Management's portfolio in Q3 2023, its #5 holding.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Infini Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.